Targacept , Inc. (NASDAQ:TRGT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.

Recs

0
Player Avatar baselineace (33.67) Submitted: 11/25/2012 11:38:26 PM : Outperform Start Price: $4.36 TRGT Score: +1.30

New CEO

Featured Broker Partners


Advertisement